Forget Moderna: This Biotech Juggernaut Is Rising Fast
A biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
Explore which performs better: index funds or mutual funds, focusing on costs, tracking error, and long-term results for investors.
24,353 articlesA biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
Navitas Semiconductor is shifting from consumer power chips to high-power markets, aligning with Nvidia's AI data-cen...
Natural gas equities are delivering higher yields than broad dividend ETFs as of 2026, driven by midstream cash flows...
Marvell Technology is set to report fiscal Q1 results after the close, with investors weighing AI demand, margins and...
South Korea authorities indict five individuals in what prosecutors call the first DEX rug pull case under the 2024 V...
Delta is expanding its premium pricing playbook, testing bigger first-class blocks, forging brand partnerships, and b...
A notable institutional purchase in Plains GP Holdings hints at a larger, value-driven view of the energy midstream s...
Institutional holders control roughly 87% of Starbucks' float, and analysts expect further upside as comps improve an...
Crypto4me has unveiled Recurring Purchases, a new feature that automates monthly crypto purchases for users, aiming t...
Airbnb's Brian Chesky is reportedly exploring a dedicated AI lab, signaling his first major push into AI. The effort ...
CONL sinks 67% year to date as COIN slides 33%, underscoring the volatility tax embedded in daily-reset leveraged ETF...
A dramatic rally has put Super Micro Computer in the spotlight. This guide breaks down what’s driving the move, how t...